MSH|^~\&|MIC|SMH|||201910291348||ORU^R01|4093000|D|2.3|||AL|NE
PID|1||SM00042062|SM41988|MICTEST^EXHAUSTED^||19700202|M||||||||||SM001890/18|9875972644
OBR|1|34626^MIC|00026605^19:W0000549R^MIC^19:W549^34626|205.2000^FLE^Eye fluid culture and gram^^^636-1||201910291222|20191029UNK|||||||201910291221|Anterior tap^^^Left|||||||||MB|F||||
OBX|1|ST|100.0500^GSF^Gram stain^^664-3^664-3^S:TNP|1|Test not performed||||||F|||201910291348
OBX|2|CE|205.1000^FLEC^Eye Fluid^^6463-4^636-1^O:SPARA|2.1|SPARA^Salmonella Paratyphi A||||||F|||201910291348
OBX|3|ST|205.1000^FLEC^Eye Fluid^^6463-4^636-1^P:AMT|2.1|||||||F|||201910291348
OBX|4|ST|205.1000^FLEC^Eye Fluid^^6463-4^636-1^R:2|2.1|2+||||||F|||201910291348
OBR|2||00026605^19:W0000549R^MIC^19:W549^34626|903.3150^N391^Vitek N391 Sensitivity^^^29576-6||201910291222|20191029UNK|||||||201910291221|Anterior tap^^^Left|||||||||MB|F|6463-4^2.1|||34626^MIC
OBX|1|ST|100.500^CAX^Ceftriaxone^^141-2^141-2|||||S|||F|||201910291348
OBX|2|ST|100.900^CFM^Cefixime^^80-2^80-2|||||S|||F|||201910291348
OBX|3|ST|200.100^AM^Ampicillin^^28-1^28-1|||||S|||F|||201910291348
OBX|4|ST|600.000^TS^Trimethoprim/sulfamethoxazole^^516-5^516-5|||||S|||F|||201910291348

MSH|^~\&|MIC|SMH|||201910291350||ORU^R01|4093001|D|2.3|||AL|NE
PID|1||SM00042062|SM41988|MICTEST^EXHAUSTED^||19700202|M||||||||||SM001890/18|9875972644
OBR|1|34627^MIC|00026605^19:W0000550R^MIC^19:W550^34627|205.2000^FLE^Eye fluid culture and gram^^^636-1||201910291222|20191029UNK|||||||201910291221|Anterior tap^^^Right|||||||||MB|F||||
OBX|1|ST|100.0500^GSF^Gram stain^^664-3^664-3^S:TNP|1|Test not performed||||||F|||201910291350
OBX|2|CE|205.1000^FLEC^Eye Fluid^^6463-4^636-1^O:SMAL|2.1|SMAL^Stenotrophomonas maltophilia||||||F|||201910291350
OBX|3|ST|205.1000^FLEC^Eye Fluid^^6463-4^636-1^P:AMT|2.1|||||||F|||201910291350
OBX|4|ST|205.1000^FLEC^Eye Fluid^^6463-4^636-1^R:FEW|2.1|Few colonies only.||||||F|||201910291350
OBX|5|ST|205.1000^FLEC^Eye Fluid^^6463-4^636-1|2.1|||||||F|||201910291350
NTE|1||Trimethoprim/sulfa is the drug of choice for
NTE|2||Stenotrophomonas.  There is limited experience with other
NTE|3||antimicrobial agents.
OBR|2||00026605^19:W0000550R^MIC^19:W550^34627|903.3150^N391^Vitek N391 Sensitivity^^^29576-6||201910291222|20191029UNK|||||||201910291221|Anterior tap^^^Right|||||||||MB|F|6463-4^2.1|||34627^MIC
OBX|1|ST|100.000^MER^Meropenem^^6652-2^6652-2|||||R|||F|||201910291350
OBX|2|ST|100.150^ETP^Ertapenem^^35801-0^35801-0|||||R|||F|||201910291350
OBX|3|ST|100.400^CFT^Cefotaxime^^108-1^108-1|||||R|||F|||201910291350
OBX|4|ST|100.500^CAX^Ceftriaxone^^141-2^141-2|||||R|||F|||201910291350
OBX|5|ST|300.100^TO^Tobramycin^^508-2^508-2|||||R|||F|||201910291350
OBX|6|ST|300.200^GM^Gentamicin^^267-5^267-5|||||R|||F|||201910291350
OBX|7|ST|500.650^CP^Ciprofloxacin^^185-9^185-9|||||R|||F|||201910291350
OBX|8|ST|600.000^TS^Trimethoprim/sulfamethoxazole^^516-5^516-5|||||S|||F|||201910291350